Back to LLY
Livforsakringsbolaget Skandia, Omsesidigt → LLY
Livforsakringsbolaget Skandia, Omsesidigt LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
10
Latest value
$45M
Q3 2026
Peak value
$46.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $4.4M |
| Q3 2025 | $15.8M |
| Q4 2025 | $5.8M |
| Q4 2025 | $26.3M |
| Q1 2026 | $5M |
| Q1 2026 | $32.8M |
| Q2 2026 | $6M |
| Q2 2026 | $46.6M |
| Q3 2026 | $3.6M |
| Q3 2026 | $45M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $45M | 38.9K | — | — |
| Q3 2026 | $3.6M | 3.1K | — | — |
| Q2 2026 | $46.6M | 38.9K | — | — |
| Q2 2026 | $6M | 5.0K | — | — |
| Q1 2026 | $32.8M | 35.6K | — | — |
| Q1 2026 | $5M | 5.4K | — | — |
| Q4 2025 | $26.3M | 24.4K | — | — |
| Q4 2025 | $5.8M | 5.4K | — | — |
| Q3 2025 | $15.8M | 20.7K | — | — |
| Q3 2025 | $4.4M | 5.8K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B